Eukaryotic cell membranes are primarily composed of phospholipids, the most abundant of which is phosphatidylcholine (PC). De novo synthesis of PC by the CDP-choline pathway is under the control of the rate-limiting enzyme CTP:phosphocholine cytidylyltransferase (CCT). The nuclear CCTa isoform is regulated by translocation to the inner nuclear membrane (INM) and nuclear lipid droplets (nLD) in response to lipid activators, such as oleate, or deficiency in PC content. CCTa association with the INM is mediated by a positively-charged membrane-binding M-domain and a phosphorylated P-domain containing 16 serine phospho-sites. Mutation of all P-domain serine residues to alanine (dephosphorylated mimic) enhanced association with nLDs in oleate-treated U2OS cells, while mutation to glutamate (phosphorylated mimic) or mutation of M-domain lysine residues ablated nLD association. However, it is unknown if phosphorylation regulation of CCTa association with the INM and nLDs involves specific serine residues or the net charge of the P-domain. To address this question, we mutated 4 sets of 2-3 serine residues in the P-domain to alanine or aspartate. CCTa cDNAs expressing different combinations of these mutations were expressed in oleate-treated U2OS cells and the frequency of nLD association was measured. The mutants were also expressed in CHO cells with a temperature-sensitive CCTα isoform and INM translocation in response to oleate was determined. The greatest inhibitory effect on INM and nLD association was observed when all 4 sets of serine residues were mutated to aspartate and not by any one site, suggesting that net charge density of the P-domain regulates affinity for the NE and nLD. Additionally, CCTa serine-to-alanine mutants expressed in U2OS cells were unstable compared to the corresponding aspartate mutants. We conclude that CCTa association with the INM and nLD is inhibited as overall P-domain phosphorylation increases. In its active membrane-associated, dephosphorylated state CCTa protein has decreased stability, a potently negative feedback mechanism to control PC synthesis. These results provide novel insight into how PC synthesis is regulated that will be essential for identifying kinases and phosphatases that act on CCTα.
This research was supported by funding by the Canadian Institute of Health Research and a Research Nova Scotia graduate student scholarship
